{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_182251.3:c.605G>A",
          "cDNA Change": {
            "transcript": "NM_182251.3",
            "ref": "G",
            "alt": "A",
            "position": "605"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "202"
          },
          "Description in input context": "G2019S variant in LRRK2 associated with Parkinson's disease"
        },
        {
          "HGVS": "NM_182251.3:c.1434C>T",
          "cDNA Change": {
            "transcript": "NM_182251.3",
            "ref": "C",
            "alt": "T",
            "position": "1434"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "478"
          },
          "Description in input context": "R478W variant in LRRK2 linked to Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005190"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with LRRK2 variants (G2019S, R478W) and wild-type controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_182251.3:c.605G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression of G2019S variant showed 30% reduction compared to wild-type."
        },
        {
          "Variant": "NM_182251.3:c.1434C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R478W variant exhibited 20% increased kinase activity in vitro."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each blot was repeated in triplicate for technical validation."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to compare variant vs. wild-type groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression â‰¥ 85% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression < 70% of wild-type control or kinase activity > 25% increase",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase Activity Assay",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "Recombinant LRRK2 proteins",
        "Description": "Recombinant LRRK2 variants (G2019S, R478W) were tested in kinase assays with ATP and substrate."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_182251.3:c.605G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "G2019S variant showed 40% reduced kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_182251.3:c.1434C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R478W variant exhibited 60% increased kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent kinase reactions were performed per variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each reaction was repeated in duplicate for technical consistency."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No enzyme (buffer only) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare kinase activity across variants."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10-15% of wild-type range",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity < 5% or > 30% deviation from wild-type",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}